Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Innovation Action · Running

Newlife New remote non-invasive monitoring solutions for ensuring the health of mothers and babies before and after birth

Coordinator
Philips Electronics Nederland BV, Netherlands
Runs
1 January 2023 to 30 June 2026
Status
Running
EU funding
€6.2m
Total cost
€21.8m
Partners
30 organisations in 6 countries
Type
Innovation Action
Grant agreement
101095792

What the project is doing

In the project's own words, from its summary on CORDIS.

There is increasing focus on the well being of mothers and babies, both before and after delivery and early detection ofpathologies to prevent mother and perinatal morbidity and mortality. The overall well being of mothers also has longer termimpact: women who remain healthy during pregnancy and after birth are more likely to stay healthy later in life and havebetter birth outcomes, also influencing the infancy, childhood and adulthood of their children.

NewLife project will develop new remote non-invasive monitoring solutions for ensuring the health of mothers and babiesbefore and after birth. The target is to develop emerging non-invasive methods for gathering vital data and analysing it withadvanced AI/ML methods, to be able to secure life in its most vulnerable phase. For clinical acceptance, the developedsolutions need to be well integrated to the clinical workflows, with proper data integration, security, safety, and medicalqualification.

The technologies and solutions developed are demonstrated in five use cases for both hospitals and personalizedmonitoring in home environments: 1) Pregnancy & parent companion, 2) Smart garment for monitoring of pregnancies& complications, 3) Fetal monitoring patch for high-risk pregnancies, 4) Newborn monitoring with smart clothes, and 5) Newbornmonitoring -well being in bed. With the developed solutions, NewLife project will contribute to the disruption of the health caremodels: by focusing on preventive actions rather than treating diseases, and moving healthcare from hospitals to home.

Who is involved

OrganisationCityCountryRole
Philips Electronics Nederland BVEindhovenNetherlandsCoordinator
Ams International AGRapperswilSwitzerlandAssociatedpartner
Csem Centre Suisse D'electronique Et De Microtechnique SA - Recherche Et DeveloppementNeuchatelSwitzerlandAssociatedpartner
Insel Gruppe AGBernSwitzerlandAssociatedpartner
Momm Diagnostics AGBaselSwitzerlandAssociatedpartner
Nanoleq AGRumlangSwitzerlandAssociatedpartner
Polar Electro Europe AG, Fleurier BranchFleurierSwitzerlandAssociatedpartner
Rekonas GmbHBaselSwitzerlandAssociatedpartner
Zoundream AGBaselSwitzerlandAssociatedpartner
Ams Sensors Germany GmbHJenaGermanyParticipant
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Nirx Medizintechnik GmbHBerlinGermanyParticipant
Philips Medizin Systeme Boblingen GmbHBoblingenGermanyParticipant
Teiimo GmbHMunchenGermanyParticipant
Fujitsu Finland OyHelsinkiFinlandParticipant
Kipuwex OyOuluFinlandParticipant
Turun YliopistoTurkuFinlandParticipant
Boston Scientific LimitedGalwayIrelandParticipant
University College Cork - National University of Ireland, CorkCorkIrelandParticipant
Club Diabetes BVVoorschotenNetherlandsThird party
HealthTalk BVVoorschotenNetherlandsThird party
Medrecord BVVoorschotenNetherlandsParticipant
Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek TNODen HaagNetherlandsParticipant
Noldus Information Technology BVWageningenNetherlandsParticipant
Sencure B.v.GroningenNetherlandsParticipant
Technische Universiteit EindhovenEindhovenNetherlandsParticipant
Beneli ABHelsingborgSwedenParticipant
Cuviva ABGoteborgSwedenParticipant
Kipuwex ABStockholmSwedenThird party
Rise Research Institutes of Sweden ABBorasSwedenParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI